1. Home
  2. PSTV vs AMS Comparison

PSTV vs AMS Comparison

Compare PSTV & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • AMS
  • Stock Information
  • Founded
  • PSTV 1996
  • AMS 1980
  • Country
  • PSTV United States
  • AMS United States
  • Employees
  • PSTV N/A
  • AMS N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • AMS Medical Specialities
  • Sector
  • PSTV Health Care
  • AMS Health Care
  • Exchange
  • PSTV Nasdaq
  • AMS Nasdaq
  • Market Cap
  • PSTV 17.0M
  • AMS 18.3M
  • IPO Year
  • PSTV N/A
  • AMS N/A
  • Fundamental
  • Price
  • PSTV $0.37
  • AMS $2.50
  • Analyst Decision
  • PSTV Strong Buy
  • AMS
  • Analyst Count
  • PSTV 3
  • AMS 0
  • Target Price
  • PSTV $10.83
  • AMS N/A
  • AVG Volume (30 Days)
  • PSTV 65.2M
  • AMS 14.8K
  • Earning Date
  • PSTV 08-13-2025
  • AMS 08-13-2025
  • Dividend Yield
  • PSTV N/A
  • AMS N/A
  • EPS Growth
  • PSTV N/A
  • AMS 151.01
  • EPS
  • PSTV N/A
  • AMS 0.21
  • Revenue
  • PSTV $5,206,000.00
  • AMS $29,236,000.00
  • Revenue This Year
  • PSTV $14.10
  • AMS $23.63
  • Revenue Next Year
  • PSTV $7.96
  • AMS N/A
  • P/E Ratio
  • PSTV N/A
  • AMS $11.96
  • Revenue Growth
  • PSTV N/A
  • AMS 35.25
  • 52 Week Low
  • PSTV $0.16
  • AMS $2.27
  • 52 Week High
  • PSTV $2.31
  • AMS $4.60
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 52.77
  • AMS 56.29
  • Support Level
  • PSTV $0.27
  • AMS $2.39
  • Resistance Level
  • PSTV $0.38
  • AMS $2.71
  • Average True Range (ATR)
  • PSTV 0.03
  • AMS 0.13
  • MACD
  • PSTV 0.01
  • AMS 0.01
  • Stochastic Oscillator
  • PSTV 81.82
  • AMS 36.00

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About AMS American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.

Share on Social Networks: